CompletedNot Applicable

NIV-Training in Hypercapnic COPD Patients

Germany30 participantsStarted 2019-01-07

Plain-language summary

The aim of the study is to investigate the additional effects of the use of NIV during exercise within a 3-week PR program on exercise capacity in COPD patients with chronic hypercapnic respiratory failure.

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of very severe COPD Gold Stage IV * Age: 40-80 years * PaCO2 \>50mmHg (at rest, during sleep or exercise) * Implemented nocturnal non-invasive ventilation therapy Exclusion Criteria: * Concomitant cardiovascular, orthopaedic or neurological conditions that are likely to be the primary impairment to exercise performance * Other significant pulmonary disease which could affect exercise or NIV (e.g. asthma) * BMI \> 35 kg/m2 * Inability to give informed consent

What they're measuring

Exercise tolerance

Timeframe: Day 1 and Day 21

Trial details

NCT IDNCT03803358

SponsorSchön Klinik Berchtesgadener Land

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-07-27

View on ClinicalTrials.gov More COPD trials